Aclid is a biotechnology company that specializes in the development of precision therapies for cancer and autoimmune diseases through the use of its proprietary SIGMA™ platform. The company focuses on discovering and targeting novel epigenetic and immune-modulatory mechanisms to create a new class of drugs.

Aclid helps scientists build safer and better biomanufactured products. The world's leading biotech manufacturers and governments rely on Aclid's security and safety products for responsible research.

BIO:ACLID

Aclid

Analysis Not Available